Savara (SVRA) Times Interest Earned (2011 - 2018)
Savara (SVRA) reported Times Interest Earned of -$105.36 for Q2 2018, down 481.9% year-over-year from $27.59 in Q2 2017, and up 65.87% quarter-over-quarter from -$308.72 in Q1 2018.
Savara (SVRA) Times Interest Earned (2011 - 2018) Analysis & Trends
Savara (SVRA) has 6 years of Times Interest Earned data on file, last reported at -$105.36 in Q2 2018.
- Times Interest Earned for Q2 2018 came in at -$105.36, down 481.9% year-over-year; the trailing twelve-month figure through Mar 2019 was -$450.07 (down 701.33% YoY), and the FY2017 annual result was -$25.8, down 6.53% from the prior year.
- Times Interest Earned grew to -$105.36 in Q2 2018 per SVRA's latest filing, from -$308.72 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$3.26 in Q1 2016 and troughed at -$10181.0 in Q2 2015.
- A 4-year average of -$857.93 and a median of -$23.62 in 2017 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2016 and 2018: Times Interest Earned soared 97.22% in 2016, then slumped 1484.35% in 2018.
- A 4-year view of Times Interest Earned shows it stood at -$3.91 in 2015, then plunged by 321.91% to -$16.51 in 2016, then plunged by 357.87% to -$75.58 in 2017, then slumped by 39.41% to -$105.36 in 2018.
- Business Quant data shows SVRA's Times Interest Earned at -$105.36 in Q2 2018, -$308.72 in Q1 2018, and -$75.58 in Q4 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -105.36 |
| Mar 31, 2018 | -308.72 |
| Dec 31, 2017 | -75.58 |
| Sep 30, 2017 | -23.62 |
| Jun 30, 2017 | -18.11 |
| Mar 31, 2017 | -19.49 |
| Dec 31, 2016 | -16.51 |
| Sep 30, 2016 | -17.00 |
| Jun 30, 2016 | -283.29 |
| Mar 31, 2016 | -3.26 |
| Dec 31, 2015 | -3.91 |
| Sep 30, 2015 | -97.31 |
| Jun 30, 2015 | -10,181.00 |
| Mar 31, 2012 | -389.50 |
| Dec 31, 2011 | -227.52 |
| Sep 30, 2011 | -13,061.93 |